You would suspect that the impending trials would be at a much higher risk of being deferred than those that have already commenced.
Hopefully (at least) those who have commenced treatment will be taken through to their intended conclusion date.
Ann: Appendix 4E and 2019 full year accounts, page-95
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.99 |
Change
0.540(2.64%) |
Mkt cap ! $2.682B | |||
| Open | High | Low | Value | Volume |
| $20.56 | $21.55 | $20.54 | $12.48M | 591.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 435 | $20.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.99 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |